Our Work

The COVID-19 pandemic disrupted traditional substance use disorder (SUD) treatment modalities, prompting innovative telemedicine solutions

It’s clear that changes in telehealth policy, mobile technology development, and consumer demand have fundamentally reshaped mental health treatment and substance use care in the US and around the world. What does this mean for people’s outcomes, specifically behavioral health care access, quality, and cost?

HBHI pilot study publication on interview findings of what clinicians and patients consider to be appropriate use of telemedicine in primary care